George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,000 shares at $660.00 ($2.0M) on 2021-11-22, disclosed to the SEC on 2021-11-23.
Seasonal sale ($2.0M) by Director — this insider has traded REGN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $655.00 | 1,000 | $655K | 33.2% |
| 2 | $655.00 | 1,000 | $655K | 33.2% |
| 3 | $660.00 | 1,000 | $660K | 33.5% |
| Total | $656.67 avg | 3,000 | $2.0M | 100% |
| Filing → |
| REGN | SELL | 2024-02-26 | $3.4M | — | Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |